Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: SD NONMETROPOLITAN AREA — October 2026
CRA pay surges locally while regulatory and data roles lag.
Metro Clinical Research Associate pay has climbed to $118,246, outpacing the $90,065 national median, even as Regulatory Affairs Specialist pay here trails the national figure by roughly $21,000.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- SD unemployment rate: 2.0% — Unchanged since August; #1 lowest among states
- Labor force participation: 66.3% — Down from 68.2% a year earlier
- CRA advertised pay (metro): $118,246 — vs $90,065 national median
- Regulatory Affairs pay (metro): $82,595 — vs $103,780 national median
Key takeaways
CRA pay has decoupled from the national market.
Metro CRA advertised pay sits roughly 31% above the national median, consistent with national reporting that experienced CRAs are the binding constraint on clinical operations capacity. Employers planning trial execution locally should expect to pay a premium well above national guidance for this role.
Regulatory affairs pay here lags the national signal.
Metro Regulatory Affairs Specialist pay is roughly $21,000 below the national median even as national demand for regulatory talent intensifies on EU and device compliance rules. A gap this size risks losing regulatory hires to remote roles paying national rates, particularly as 25% of the life sciences workforce nears retirement age.
Novartis's local pay bands are now the market anchor.
Published Novartis ranges — Executive Director, Development Sciences at $288,400–$535,600, and Principal Scientist roles above $100,000 — set a visible local ceiling that smaller biotech and device employers must either match or explicitly compete against on non-pay terms. Build-vs-outsource decisions for R&D-adjacent roles should factor this pricing in directly.
Participation decline is tightening supply faster than postings suggest.
A 1.9-point drop in labor force participation year-over-year removes workers from the active pool even as postings tick upward, meaning the same job ad volume now competes for fewer available candidates. Retention planning for credentialed quality, manufacturing and clinical staff carries more weight than external recruiting in this environment.
Median advertised pay by role — SD NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $130,053 | $142,020 | Significant increase | $130,339 |
| Clinical Research Associate | $78,416 | $118,246 | $123,941 | Significant increase | $90,065 |
| Lab Technician * | $38,403 | $46,619 | $50,921 | Significant increase | $47,840 |
| Regulatory Affairs Specialist * | $75,529 | $82,595 | $82,668 | Stable | $103,780 |
| Clinical Data Manager * | $93,503 | $100,136 | $105,400 | Significant decline | $123,653 |
| Biostatistician * | $64,251 | $88,660 | $105,178 | Significant decline | $131,958 |
| Validation Engineer | — | — | — | No data | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
South Dakota's unemployment held at 2.0% in September, but labor force participation dropped to 66.3% from 68.2% a year earlier, shrinking the active candidate pool even as job postings edged up 1.5% month-over-month into October. For Life Sci employers in nonmetropolitan South Dakota, this combination of structural labor scarcity and sustained hiring demand — against a backdrop of at least three statewide job openings per unemployed worker — means the constraint is on the supply side.
What it means
Clinical Research Associate advertised pay in this metro has climbed to a $118,246 median, running well above the $90,065 national figure — a sign that employers here are bidding aggressively for a role national data already flags as the top pharma hiring bottleneck in 2026. Meanwhile Regulatory Affairs Specialist and Clinical Data Manager pay in this metro sits meaningfully below national medians, suggesting uneven competitiveness across functions and no uniform premium. Organizations should evaluate compensation function-by-function against this metro's own movement, using that as the benchmark instead of a blended regional average, before assuming current offers are competitive.
Looking ahead
Early indicator: Watch whether Inanovate's CLIA Laboratory buildout and its Technical Supervisor search clear in a reasonable timeframe — a prolonged fill signals how deep the credentialed-talent shortage runs for smaller biotech employers competing against Novartis-level pay.
Emerging pressure point: Labor force participation has fallen 1.9 points year-over-year with no sign of reversal. If this trend continues through year-end, expect further upward pressure on advertised pay for CRA, manufacturing and quality roles regardless of national wage trends.
Worth watching: Biostatistician and Clinical Data Manager advertised pay here trail national medians by $40,000-plus. Monitor whether remote-eligible postings for these roles begin pulling local candidates toward out-of-state employers paying national rates.
Potential inflection point: October's modest postings gain (+1.5% month-over-month, job ads being a signal of hiring demand where one ad often covers several openings) comes alongside national biopharma hiring recovery — 64% of surveyed organizations are actively recruiting. If that national momentum reaches South Dakota's R&D and manufacturing employers, expect compounding pressure on an already constrained local labor pool.
Sources
- South Dakota Department of Labor and Regulation — SD unemployment held at 2.0% in September 2026
- Mitchell Republic / SD Governor's Council of Economic Advisors — Labor force participation fell to 66.3% from 68.2%
- Job Market Health — SD job postings rose 1.5% month-over-month into October
- Industry biopharma hiring survey (2026) — CRAs are the primary bottleneck in pharma hiring nationally
- Novartis job postings — Novartis South Dakota salary bands for R&D roles
- South Dakota Department of Labor and Regulation — South Dakota has at least three job openings per unemployed person
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.